By Dr Chung-Liang Shih For decades, hepatitis C has been recognised as a major global public health challenge, with an estimated 58 million people living with chronic hepatitis C infection worldwide. Although no vaccine currently exists, hepatitis C is now curable with highly effective direct-acting antiviral (DAA) therapies delivered through treatment courses of 8–12 weeks. Therefore, the World Health Organization (WHO) launched the Glasgow Dec…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.